General
Johnson & Johnson single-dose vaccine shown to be effective against COVID-19
Johnson & Johnson’s (J&J) vaccine candidate appears to protect against COVID-19 with just one shot of the dose.
Key points:
- Johnson & Johnson says trial results show its one-shot vaccine is 66 per cent effective against COVID-19
- While promising, it is still behind many rivals who are using a two-shot vaccine
- The company says trying to create a vaccine which requires one shot is worthwhile as the virus continues to spread
The single-shot option is not as strong as some of its two-shot rivals, however it could be potentially helpful for a world in dire need of more doses.
J&J said on Friday that in the US and seven other countries, the single-shot vaccine was 66 per cent per cent effective overall at preventing moderate to severe illness.
The…
-
Noosa News22 hours agoWoman dead and man rushed to hospital with gunshot wound following crash near Aussie World on Queensland’s Sunshine Coast
-
Noosa News23 hours agoBrisbane-bound traffic diverted after pile-ups along Bruce Highway
-
Noosa News22 hours agoMan arrested after police chase: Driver shot, woman dies in crash
-
General20 hours agoSummah Richards, 12, mourned after fatal e-scooter in Laidley, Queensland